Items created by Bakker, Emyr

Article

Bakker, Emyr ORCID: 0000-0002-0091-1029, Dixon, Peter Anthony ORCID: 0009-0004-5981-2959, Smith, Tim ORCID: 0009-0004-9122-6239 and Rutt-howard, Jane (2024) Predictive Modelling of the UK Physician Associate Supply: 2014-2038. Future Healthcare Journal, 11 (4). p. 100176. ISSN 2514-6645

Montalbo, Kristy, Stasik, Izabela ORCID: 0000-0002-7756-4731, Bakker, Emyr ORCID: 0000-0002-0091-1029 and Smith, Christopher George severin ORCID: 0000-0002-6541-9035 (2024) EXPLORING MOLECULAR LINKS IN BRAIN TUMOUR BIOPSY TISSUES AND ALZHEIMER’S DISEASE. Neuro-Oncology, 26 (Supp7). vii17-vii17. ISSN 1522-8517

Shah, Maria, Smith, Stuart, Bakker, Emyr ORCID: 0000-0002-0091-1029 and Rahman, Ruman (2024) TARGETING RESIDUAL CANCER FROM THE INVASIVE MARGIN OF GLIOBLASTOMA USING COMPUTATIONAL TOOLKITS. Neuro-Oncology, 26 (Supp7). vii7-vii7. ISSN 1522-8517

Bakker, Emyr ORCID: 0000-0002-0091-1029, Rutt-howard, Jane and Norris, Rachel (2023) A 4-Year Undergraduate Route to UK Physician Associate qualification. Journal of Physician Assistant Education, 34 (3). pp. 260-264. ISSN 1941-9430

Pentimalli, Francesca, Krstic-Demonacos, Marija, Costa, Caterina, Mutti, Luciano and Bakker, Emyr ORCID: 0000-0002-0091-1029 (2023) Intratumor microbiota as a novel potential prognostic indicator in mesothelioma. Frontiers in Immunology, 14 .

O’Connor, Geraldine M. and Bakker, Emyr Y. ORCID: 0000-0002-0091-1029 (2022) Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma. BioMedInformatics, 2 (4). pp. 580-592.

Montalbo, Kristy, Bakker, Emyr ORCID: 0000-0002-0091-1029, Stasik, Izabela ORCID: 0000-0002-7756-4731 and Smith, Christopher George severin ORCID: 0000-0002-6541-9035 (2022) Exploring a Link Between Alzheimer’s and Glioma by Investigating SORL1 Network. Neuro-Oncology, 24 (Supple). iv22-iv22. ISSN 1523-5866

Bakker, Emyr ORCID: 0000-0002-0091-1029, Fujii, Masayuki, Krstic‑Demonacos, Marija, Demonacos, Constantinos and Alhammad, Rashed (2022) Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies. International Journal of Oncology, 60 (2). ISSN 1019-6439

Kannan, Siddarth, O’Connor, Geraldine ORCID: 0000-0002-7440-162X and Bakker, Emyr ORCID: 0000-0002-0091-1029 (2021) Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study. International Journal of Molecular Sciences, 22 (11). e5478. ISSN 1661-6596

Leung, Ka Lun, Verma, Devika, Azam, Younus Jamal and Bakker, Emyr ORCID: 0000-0002-0091-1029 (2020) The use of multi-omics data and approaches in breast cancer immunotherapy: a review. Future Oncology, 16 (27). ISSN 1479-6694

Meysami, Parisa, Rezaei, Farhad, Marashi, Sayed Mahdi, Amiri, Mohammad Mehdi, Bakker, Emyr ORCID: 0000-0002-0091-1029 and Mokhtari-Azad, Talat (2019) Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells. Future Virology, 14 (3). ISSN 1746-0794

Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Demonacos, Constantinos, Giordano, Antonio, Krstic-Demonacos, Marija and Mutti, Luciano (2019) BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. International Journal of Molecular Sciences, 20 (2). ISSN 1661-6596

Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Bonanni, Ezio, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2019) What can independent research for mesothelioma achieve to treat this orphan disease? Expert Opinion on Investigational Drugs, 28 (8). pp. 719-732. ISSN 1354-3784

Tian, Kun, Bakker, Emyr ORCID: 0000-0002-0091-1029, Hussain, Michelle, Guazzelli, Alice, Alhebshi, Hasen, Meysami, Parisa, Demonacos, Constantinos, Schwartz, Jean-Marc, Mutti, Luciano et al (2018) p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification. Journal of Translational Medicine, 16 . p. 282.

Bakker, Emyr ORCID: 0000-0002-0091-1029, Tian, Kun, Mutti, Luciano, Demonacos, Constantinos, Schwartz, Jean-Marc and Krstic-Demonacos, Marija (2017) Insight into glucocorticoid receptor signalling through interactome model analysis. PLoS computational biology, 13 (11). e1005825. ISSN 1553-734X

Bakker, Emyr ORCID: 0000-0002-0091-1029, Guazzelli, Alice, Ashtiani, Firozeh, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2017) Immunotherapy advances for mesothelioma treatment. Expert Review of Anticancer Therapy, 17 (9). pp. 799-814. ISSN 1473-7140

Guazzelli, Alice, Bakker, Emyr ORCID: 0000-0002-0091-1029, Tian, Kun, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2017) Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma. Expert Opinion on Investigational Drugs, 26 (8). pp. 933-944. ISSN 1354-3784

Qattan, Malak Yahia, Bakker, Emyr ORCID: 0000-0002-0091-1029, Rajendran, Ramkumar, Chen, Daphne Wei-Chen, Saha, Vaskar, Liu, Jizhong, Zeef, Leo, Schwartz, Jean-Marc, Mutti, Luciano et al (2017) Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia. PloS one, 12 (6). e0178606.

Bakker, Emyr ORCID: 0000-0002-0091-1029, Guazzelli, Alice, Krstic-Demonacos, Marija, Sotgia, Federica, Lisanti, Michael and Mutti, Luciano (2017) Current and prospective pharmacotherapies for the treatment of pleural mesothelioma. Expert Opinion on Orphan Drugs, 5 (6). pp. 455-465.

Guazzelli, Alice, Bakker, Emyr ORCID: 0000-0002-0091-1029, Krstic-Demonacos, Marija, Lisanti, Michael P, Sotgia, Federica and Mutti, Luciano (2017) Anti-CTLA-4 therapy for malignant mesothelioma. Immunotherapy, 9 (3). pp. 273-280. ISSN 1750-743X

Bakker, Emyr ORCID: 0000-0002-0091-1029, Qattan, Malak, Mutti, Luciano, Demonacos, Constantinos and Krstic-Demonacos, Marija (2015) The role of microenvironment and immunity in drug response in leukemia. BBA - Biochimica et Biophysica Acta, 1863 (3). pp. 414-426. ISSN 0006-3002